ANAPC2 p.Phe331Ser
c.992T>C · VCV4048999
Computational evidence
| Protein change | ||
| AlphaMissense | 0.8633 | likely pathogenic |
|---|---|---|
| REVEL | 0.357 | indeterminate |
| SaProt | LLR -4.24 | tolerated |
| ⇒ AlphaMissense calls this damaging; SaProt does not; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | <0.2 | all four deltas below 0.2 · A>T here scores Δ0.87 · evaluated, not missing |
| Constraint at this position | ||
| Conservation | phyloP 9.2 | GERP 1, phastCons 1 |
| Regional constraint | o/e 0.83 | unconstrained · MANE · 4,832 bp · p 0.00015 · regional, not allelic |
| Overall | ||
| CADD | 25.0 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.
Variant & gene context
- Gene
- ANAPC2
- Protein
- p.Phe331Ser
- Coding
- c.992T>C
- MANE Select
- NM_013366
- Type
- single nucleotide variant
- Location
- chr9:137184969 (GRCh38)
- Gene constraint
- LOEUF 0.482 · pLI 0.99 (gnomAD)
- Structure
- AlphaFold pLDDT 79.44 · 23 PDB
- Residue 331
- an α-helix
Similar variants
- ANAPC2 p.Ala664= Benign/Likely benign ★★ same type
- ANAPC2 p.Tyr509= Benign ★★ same type
- ANAPC2 p.Ala36Val Uncertain significance ★ ⚠ same type
- ANAPC2 p.Ala380Asp Uncertain significance ★ ⚠ same type
- ANAPC2 p.Ala4Val Uncertain significance ★ ⚠ same type
- ANAPC2 p.Arg121Leu Uncertain significance ★ ⚠ same type
- ANAPC2 p.Arg210His Uncertain significance ★ ⚠ same type
- ANAPC2 p.Arg270Gln Uncertain significance ★ ⚠ same type
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/anapc2-p-phe331ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown